[go: up one dir, main page]

IN2013MU01241A - - Google Patents

Info

Publication number
IN2013MU01241A
IN2013MU01241A IN1241MU2013A IN2013MU01241A IN 2013MU01241 A IN2013MU01241 A IN 2013MU01241A IN 1241MU2013 A IN1241MU2013 A IN 1241MU2013A IN 2013MU01241 A IN2013MU01241 A IN 2013MU01241A
Authority
IN
India
Prior art keywords
methylphenidate
salts
release
pharmaceutical compositions
relates
Prior art date
Application number
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Jitendrakumar Chordiya
Inderjeetsingh Huda
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/060084 priority Critical patent/WO2014174388A1/en
Priority to IN1241MU2013 priority patent/IN2013MU01241A/en
Publication of IN2013MU01241A publication Critical patent/IN2013MU01241A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a process for preparing modified release pharmaceutical compositions of methylphenidate or salts thereof. In particular, the present invention relates to modified release pharmaceutical compositions comprising at least one immediate release and at least one extended release component of methylphenidate or salts thereof. The composition may provide extended and specific release of methylphenidate or salts thereof to achieve therapeutically effective plasma concentration over a period of 12 hours to treat attention deficit disorders when administered to a patient in need thereof.
IN1241MU2013 2013-03-29 2014-03-24 IN2013MU01241A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/060084 WO2014174388A1 (en) 2013-03-29 2014-03-24 Modified release pharmaceutical compositions of methylphenidate or salts thereof
IN1241MU2013 IN2013MU01241A (en) 2013-03-29 2014-03-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1241MU2013 IN2013MU01241A (en) 2013-03-29 2014-03-24

Publications (1)

Publication Number Publication Date
IN2013MU01241A true IN2013MU01241A (en) 2015-04-17

Family

ID=54395625

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1241MU2013 IN2013MU01241A (en) 2013-03-29 2014-03-24

Country Status (1)

Country Link
IN (1) IN2013MU01241A (en)

Similar Documents

Publication Publication Date Title
PH12019502355A1 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
BR112015003188A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, COMPOUND USE, AND METHOD FOR TREATMENT OF A RORGAMMAT-MEDIATED DISEASE OR CONDITION IN A PATIENT
MX2013011691A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
TN2015000278A1 (en) Autotaxin inhibitors
MY182558A (en) 1,2,4-triazine derivatives for the treatment of viral infections
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX367926B (en) Pharmaceutical composition for a sustained release of lanreotide.
MX342119B (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators.
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.
IN2014DN09437A (en)
GB201115977D0 (en) Neurodevelopmental disorders
MX2013002295A (en) Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators.
IN2013MU01242A (en)
IN2013MU01241A (en)
IN2013MU01240A (en)
IN2013MU01247A (en)
IN2013MU01244A (en)
IN2013MU01248A (en)
IN2013MU01250A (en)
IN2013MU01249A (en)
IN2013MU01246A (en)
IN2013MU01245A (en)
IN2013MU01239A (en)
IN2013MU01243A (en)